Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19”

Detalles Bibliográficos
Autores principales: Buonomo, Antonio Riccardo, Viceconte, Giulio, Gentile, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647515/
https://www.ncbi.nlm.nih.gov/pubmed/34872608
http://dx.doi.org/10.1186/s13054-021-03836-7
_version_ 1784610620637708288
author Buonomo, Antonio Riccardo
Viceconte, Giulio
Gentile, Ivan
author_facet Buonomo, Antonio Riccardo
Viceconte, Giulio
Gentile, Ivan
author_sort Buonomo, Antonio Riccardo
collection PubMed
description
format Online
Article
Text
id pubmed-8647515
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86475152021-12-06 Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19” Buonomo, Antonio Riccardo Viceconte, Giulio Gentile, Ivan Crit Care Letter BioMed Central 2021-12-06 /pmc/articles/PMC8647515/ /pubmed/34872608 http://dx.doi.org/10.1186/s13054-021-03836-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter
Buonomo, Antonio Riccardo
Viceconte, Giulio
Gentile, Ivan
Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19”
title Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19”
title_full Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19”
title_fullStr Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19”
title_full_unstemmed Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19”
title_short Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19”
title_sort pneumocystis jirovecii pneumonia in covid-19: an overlooked clinical entity—response to “pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to covid 19”
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647515/
https://www.ncbi.nlm.nih.gov/pubmed/34872608
http://dx.doi.org/10.1186/s13054-021-03836-7
work_keys_str_mv AT buonomoantonioriccardo pneumocystisjiroveciipneumoniaincovid19anoverlookedclinicalentityresponsetopneumocystispneumoniariskamongviralacuterespiratorydistresssyndromerelatedornottocovid19
AT vicecontegiulio pneumocystisjiroveciipneumoniaincovid19anoverlookedclinicalentityresponsetopneumocystispneumoniariskamongviralacuterespiratorydistresssyndromerelatedornottocovid19
AT gentileivan pneumocystisjiroveciipneumoniaincovid19anoverlookedclinicalentityresponsetopneumocystispneumoniariskamongviralacuterespiratorydistresssyndromerelatedornottocovid19

Ejemplares similares